ViCentra BV, Medical Devices, Utrecht Founded in 2013 in Utrecht, The Netherlands, ViCentra is a leading early stage commercial company focused on the development, manufacturing and commercialisation of the Kaleido insulin pump designed to help people with diabetes live life on their own terms. Driven by our belief in the power of innovative healthcare products that put the people first and a desire to be meaningfully different, Kaleido aims to reduce the impact that diabetes can have on daily life.
| Website | http://www.hellokaleido.com |
| Revenue | $20.7 million |
| Employees | 201 (138 on RocketReach) |
| Founded | 2013 |
| Technologies |
JavaScript
,
HTML
,
PHP
+39 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Diabetes Care, Medical Devices Manufacturing, Diabetes Management, Diabetes Technology, Drug Delivery, Healthcare Technology, Medical Technology, Health Tech, Type 1 Diabetes, Type 2 Diabetes, Blood Glucose Monitoring |
| Competitors | Amgen, Twist Bioscience, Novo Holdings, Zymeworks Inc., Seres Therapeutics, Geno, Zymergen, Inc., Human Longevity, Inc., Elysium Health, Sierra Oncology +39 more (view full list) |
Looking for a particular Vicentra employee's phone or email?
The Vicentra annual revenue was $20.7 million in 2026.
Thomas Arnold is the CEO of Vicentra.
138 people are employed at Vicentra.